We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Toward clinical transparency.
- Abstract
The author reflects on an announcement made by GlaxoSmithKline (GSK) regarding the availability of detailed anonymized patient-level data from their clinical trials to qualified researchers. The author mentions that GSK committed for increasing the transparency of its studies and to increase openness. The author states that GSK will create a secure website containing detailed patient data and the full protocols of clinical trials for implementation of its transparency related programs.
- Subjects
GLAXOSMITHKLINE; DATA; CLINICAL trials; TRANSPARENCY (Optics); WEBSITES; MEDICAL protocols
- Publication
Nature Medicine, 2012, Vol 18, Issue 11, p1593
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm.3000